AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q3 2019 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST)
Q3 2019 Earnings Conference Call
November 06, 2019 08:00 AM ET
Company Participants
Stephanie Carrington - Westwicke Investor Relations
Keith Kendall - Chief Executive Officer
John Maxwell - Chief Financial Officer
Ken Marshall - Chief Commercial Officer
Dan Barber - Senior Vice President & Chief Operating Officer
Conference Call Participants
Rafay Sardar - BMO Capital Markets
Liana Moussatos - Wedbush Securities
Jason Butler - JMP Securities
Thomas Flaten - Lake Street Capital
Ram Selvaraju - H.C. Wainwright
Presentation
Operator
Good morning, and welcome to the Aquestive Therapeutics' Third Quarter Conference Call.